| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 4.75e-06 | 2 | 44 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 4.75e-06 | 2 | 44 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 3.64e-04 | 13 | 44 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 6.32e-04 | 17 | 44 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 1.86e-03 | 29 | 44 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.55e-03 | 34 | 44 | 2 | GO:0008395 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.88e-03 | 129 | 44 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.47e-03 | 151 | 44 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 5.65e-03 | 51 | 44 | 2 | GO:0003743 | |
| GeneOntologyMolecularFunction | iron ion binding | 5.82e-03 | 166 | 44 | 3 | GO:0005506 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by chemical signal | 7.03e-07 | 9 | 43 | 3 | GO:0003062 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 1.26e-05 | 381 | 43 | 7 | GO:0071375 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 1.27e-05 | 3 | 43 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 2.12e-05 | 26 | 43 | 3 | GO:0014061 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 2.54e-05 | 4 | 43 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 2.54e-05 | 4 | 43 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 2.67e-05 | 28 | 43 | 3 | GO:0048243 | |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 2.67e-05 | 83 | 43 | 4 | GO:0042446 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 4.23e-05 | 5 | 43 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | positive regulation of neuronal action potential | 6.33e-05 | 6 | 43 | 2 | GO:1904457 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 6.77e-05 | 38 | 43 | 3 | GO:0015874 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 9.15e-05 | 42 | 43 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 1.03e-04 | 530 | 43 | 7 | GO:0043434 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational initiation | 1.13e-04 | 45 | 43 | 3 | GO:0002183 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 1.29e-04 | 237 | 43 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | formation of translation preinitiation complex | 1.89e-04 | 10 | 43 | 2 | GO:0001731 | |
| GeneOntologyBiologicalProcess | cortisol biosynthetic process | 1.89e-04 | 10 | 43 | 2 | GO:0034651 | |
| GeneOntologyBiologicalProcess | tertiary alcohol biosynthetic process | 1.89e-04 | 10 | 43 | 2 | GO:1902645 | |
| GeneOntologyBiologicalProcess | aldosterone biosynthetic process | 2.31e-04 | 11 | 43 | 2 | GO:0032342 | |
| GeneOntologyBiologicalProcess | organic cation transport | 2.34e-04 | 145 | 43 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 2.41e-04 | 271 | 43 | 5 | GO:0032869 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 2.53e-04 | 59 | 43 | 3 | GO:0045777 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 2.66e-04 | 60 | 43 | 3 | GO:1904037 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 2.67e-04 | 277 | 43 | 5 | GO:1901617 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 2.76e-04 | 279 | 43 | 5 | GO:0042180 | |
| GeneOntologyBiologicalProcess | cortisol metabolic process | 2.77e-04 | 12 | 43 | 2 | GO:0034650 | |
| GeneOntologyBiologicalProcess | negative regulation of insulin secretion | 2.93e-04 | 62 | 43 | 3 | GO:0046676 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.07e-04 | 63 | 43 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | mineralocorticoid biosynthetic process | 3.26e-04 | 13 | 43 | 2 | GO:0006705 | |
| GeneOntologyBiologicalProcess | positive regulation of transmission of nerve impulse | 3.26e-04 | 13 | 43 | 2 | GO:0051971 | |
| GeneOntologyBiologicalProcess | blood circulation | 3.52e-04 | 648 | 43 | 7 | GO:0008015 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 3.68e-04 | 67 | 43 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | primary alcohol biosynthetic process | 3.80e-04 | 14 | 43 | 2 | GO:0034309 | |
| GeneOntologyBiologicalProcess | aldosterone metabolic process | 3.80e-04 | 14 | 43 | 2 | GO:0032341 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.02e-04 | 69 | 43 | 3 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 4.38e-04 | 15 | 43 | 2 | GO:0098908 | |
| GeneOntologyBiologicalProcess | protein secretion | 4.52e-04 | 480 | 43 | 6 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 4.67e-04 | 483 | 43 | 6 | GO:0035592 | |
| GeneOntologyBiologicalProcess | negative regulation of peptide hormone secretion | 4.74e-04 | 73 | 43 | 3 | GO:0090278 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 5.04e-04 | 490 | 43 | 6 | GO:0071692 | |
| GeneOntologyBiologicalProcess | negative regulation of peptide secretion | 5.13e-04 | 75 | 43 | 3 | GO:0002792 | |
| GeneOntologyBiologicalProcess | mineralocorticoid metabolic process | 5.66e-04 | 17 | 43 | 2 | GO:0008212 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 5.98e-04 | 79 | 43 | 3 | GO:0050432 | |
| GeneOntologyBiologicalProcess | drinking behavior | 6.36e-04 | 18 | 43 | 2 | GO:0042756 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 6.36e-04 | 18 | 43 | 2 | GO:0045760 | |
| GeneOntologyBiologicalProcess | glucocorticoid biosynthetic process | 6.36e-04 | 18 | 43 | 2 | GO:0006704 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of blood volume | 6.36e-04 | 18 | 43 | 2 | GO:0001977 | |
| GeneOntologyBiologicalProcess | response to insulin | 6.99e-04 | 342 | 43 | 5 | GO:0032868 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 7.00e-04 | 727 | 43 | 7 | GO:0032870 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.35e-04 | 733 | 43 | 7 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 7.75e-04 | 350 | 43 | 5 | GO:0050708 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 8.54e-04 | 752 | 43 | 7 | GO:1901699 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 9.23e-04 | 1249 | 43 | 9 | GO:0048878 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 9.28e-04 | 209 | 43 | 4 | GO:0006694 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 9.55e-04 | 22 | 43 | 2 | GO:1902644 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 1.01e-03 | 214 | 43 | 4 | GO:1903531 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.04e-03 | 23 | 43 | 2 | GO:0001991 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 1.05e-03 | 96 | 43 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.24e-03 | 1042 | 43 | 8 | GO:0009725 | |
| GeneOntologyBiologicalProcess | negative regulation of protein secretion | 1.29e-03 | 103 | 43 | 3 | GO:0050709 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone secretion | 1.29e-03 | 103 | 43 | 3 | GO:0046888 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone biosynthetic process | 1.34e-03 | 26 | 43 | 2 | GO:0006700 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion | 1.34e-03 | 231 | 43 | 4 | GO:0050796 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.41e-03 | 1064 | 43 | 8 | GO:0032940 | |
| GeneOntologyBiologicalProcess | glucocorticoid metabolic process | 1.44e-03 | 27 | 43 | 2 | GO:0008211 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.52e-03 | 239 | 43 | 4 | GO:0051048 | |
| GeneOntologyBiologicalProcess | regulation of transmission of nerve impulse | 1.55e-03 | 28 | 43 | 2 | GO:0051969 | |
| GeneOntologyBiologicalProcess | positive regulation of systemic arterial blood pressure | 1.55e-03 | 28 | 43 | 2 | GO:0003084 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.64e-03 | 112 | 43 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.82e-03 | 116 | 43 | 3 | GO:0015844 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 1.90e-03 | 31 | 43 | 2 | GO:0046184 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of systemic arterial blood pressure | 1.90e-03 | 31 | 43 | 2 | GO:0003071 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 2.02e-03 | 641 | 43 | 6 | GO:1901615 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization | 2.16e-03 | 263 | 43 | 4 | GO:1903828 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 2.25e-03 | 125 | 43 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | export from cell | 2.35e-03 | 1153 | 43 | 8 | GO:0140352 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 2.42e-03 | 35 | 43 | 2 | GO:0120255 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 2.46e-03 | 129 | 43 | 3 | GO:0002027 | |
| GeneOntologyBiologicalProcess | insulin secretion | 2.50e-03 | 274 | 43 | 4 | GO:0030073 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 2.56e-03 | 36 | 43 | 2 | GO:0046885 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 2.60e-03 | 277 | 43 | 4 | GO:0090276 | |
| GeneOntologyBiologicalProcess | translational initiation | 2.62e-03 | 132 | 43 | 3 | GO:0006413 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by renin-angiotensin | 2.70e-03 | 37 | 43 | 2 | GO:0003081 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 2.78e-03 | 282 | 43 | 4 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 2.78e-03 | 282 | 43 | 4 | GO:0002791 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 2.79e-03 | 684 | 43 | 6 | GO:0010817 | |
| GeneOntologyBiologicalProcess | chemokine production | 2.79e-03 | 135 | 43 | 3 | GO:0032602 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 6.46e-05 | 6 | 44 | 2 | GO:0005850 | |
| HumanPheno | Secretory adrenocortical adenoma | 3.53e-05 | 3 | 18 | 2 | HP:0011746 | |
| HumanPheno | Dexamethasone-suppressible primary hyperaldosteronism | 1.17e-04 | 5 | 18 | 2 | HP:0011739 | |
| HumanPheno | Lactose intolerance | 1.17e-04 | 5 | 18 | 2 | HP:0004789 | |
| MousePheno | abnormal urine progesterone level | 7.20e-06 | 2 | 38 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 7.20e-06 | 2 | 38 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 7.20e-06 | 2 | 38 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 7.20e-06 | 2 | 38 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 7.20e-06 | 2 | 38 | 2 | MP:0011546 | |
| MousePheno | decreased lipid level | SREBF1 DMXL2 LLGL2 MALRD1 TIAL1 MTOR CYP11B1 FFAR3 CYP11B2 GPR42 | 1.70e-05 | 727 | 38 | 10 | MP:0014461 |
| MousePheno | abnormal sympathetic neuron innervation pattern | 2.15e-05 | 3 | 38 | 2 | MP:0009284 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 4.30e-05 | 4 | 38 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 4.30e-05 | 4 | 38 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 4.30e-05 | 4 | 38 | 2 | MP:0011539 | |
| MousePheno | abnormal sympathetic neuron physiology | 4.30e-05 | 4 | 38 | 2 | MP:0009253 | |
| MousePheno | abnormal urine corticosterone level | 4.30e-05 | 4 | 38 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 4.30e-05 | 4 | 38 | 2 | MP:0014459 | |
| MousePheno | increased adrenal gland zona fasciculata size | 7.16e-05 | 5 | 38 | 2 | MP:0014286 | |
| MousePheno | uterus adenomyosis | 1.07e-04 | 6 | 38 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 1.07e-04 | 6 | 38 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 1.07e-04 | 6 | 38 | 2 | MP:0009078 | |
| MousePheno | decreased circulating noradrenaline level | 1.50e-04 | 7 | 38 | 2 | MP:0005664 | |
| MousePheno | abnormal urine hormone level | 1.50e-04 | 7 | 38 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 1.50e-04 | 7 | 38 | 2 | MP:0000635 | |
| MousePheno | increased circulating ketone body level | 1.58e-04 | 39 | 38 | 3 | MP:0002575 | |
| MousePheno | increased circulating angiotensin II level | 1.99e-04 | 8 | 38 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 1.99e-04 | 8 | 38 | 2 | MP:0031229 | |
| MousePheno | ketosis | 2.12e-04 | 43 | 38 | 3 | MP:0030970 | |
| MousePheno | decreased circulating renin level | 3.19e-04 | 10 | 38 | 2 | MP:0003353 | |
| MousePheno | abnormal adrenocortical cell morphology | 3.19e-04 | 10 | 38 | 2 | MP:0008291 | |
| MousePheno | enlarged kidney | 3.52e-04 | 354 | 38 | 6 | MP:0003068 | |
| MousePheno | abnormal adrenal gland zona fasciculata size | 3.90e-04 | 11 | 38 | 2 | MP:0014284 | |
| MousePheno | abnormal sympathetic neuron morphology | 3.90e-04 | 11 | 38 | 2 | MP:0001025 | |
| MousePheno | uterus cyst | 3.90e-04 | 11 | 38 | 2 | MP:0009082 | |
| MousePheno | abnormal circulating ketone body level | 4.18e-04 | 54 | 38 | 3 | MP:0003457 | |
| MousePheno | abnormal circulating angiotensin II level | 4.67e-04 | 12 | 38 | 2 | MP:0031230 | |
| MousePheno | abnormal angiotensin II level | 4.67e-04 | 12 | 38 | 2 | MP:0031227 | |
| MousePheno | hypokalemia | 4.67e-04 | 12 | 38 | 2 | MP:0004119 | |
| MousePheno | enlarged pituitary gland | 4.67e-04 | 12 | 38 | 2 | MP:0000636 | |
| MousePheno | abnormal pituitary gland morphology | 4.76e-04 | 135 | 38 | 4 | MP:0000633 | |
| MousePheno | abnormal noradrenaline level | 6.27e-04 | 62 | 38 | 3 | MP:0003964 | |
| MousePheno | increased renin activity | 6.41e-04 | 14 | 38 | 2 | MP:0005582 | |
| MousePheno | decreased circulating mineralocorticoid level | 6.41e-04 | 14 | 38 | 2 | MP:0003374 | |
| MousePheno | increased urine osmolality | 6.41e-04 | 14 | 38 | 2 | MP:0008055 | |
| MousePheno | increased circulating adrenocorticotropin level | 6.41e-04 | 14 | 38 | 2 | MP:0001748 | |
| MousePheno | decreased circulating aldosterone level | 6.41e-04 | 14 | 38 | 2 | MP:0002667 | |
| MousePheno | endometrium hyperplasia | 6.41e-04 | 14 | 38 | 2 | MP:0009092 | |
| MousePheno | decreased circulating cholesterol level | 6.46e-04 | 397 | 38 | 6 | MP:0005179 | |
| MousePheno | abnormal neuroendocrine gland morphology | 8.20e-04 | 156 | 38 | 4 | MP:0000631 | |
| MousePheno | decreased cholesterol level | 8.45e-04 | 418 | 38 | 6 | MP:0003983 | |
| MousePheno | decreased sterol level | 8.78e-04 | 421 | 38 | 6 | MP:0012225 | |
| MousePheno | abnormal intestinal transit time | 9.54e-04 | 17 | 38 | 2 | MP:0006001 | |
| MousePheno | abnormal adrenal gland zona fasciculata morphology | 1.20e-03 | 19 | 38 | 2 | MP:0008294 | |
| MousePheno | abnormal circulating noradrenaline level | 1.20e-03 | 19 | 38 | 2 | MP:0005663 | |
| MousePheno | abnormal diencephalon morphology | 1.20e-03 | 298 | 38 | 5 | MP:0000830 | |
| MousePheno | abnormal renin activity | 1.33e-03 | 20 | 38 | 2 | MP:0005581 | |
| MousePheno | increased adrenocorticotropin level | 1.61e-03 | 22 | 38 | 2 | MP:0005129 | |
| MousePheno | increased circulating renin level | 1.76e-03 | 23 | 38 | 2 | MP:0003352 | |
| MousePheno | oliguria | 1.91e-03 | 24 | 38 | 2 | MP:0003620 | |
| MousePheno | postnatal lethality, incomplete penetrance | 1.92e-03 | 669 | 38 | 7 | MP:0011086 | |
| MousePheno | decreased noradrenaline level | 2.08e-03 | 25 | 38 | 2 | MP:0012574 | |
| MousePheno | decreased liver triglyceride level | 2.09e-03 | 94 | 38 | 3 | MP:0009356 | |
| MousePheno | hypotension | 2.60e-03 | 28 | 38 | 2 | MP:0001596 | |
| MousePheno | abnormal circulating renin level | 2.79e-03 | 29 | 38 | 2 | MP:0003349 | |
| MousePheno | abnormal sympathetic nervous system physiology | 2.79e-03 | 29 | 38 | 2 | MP:0004183 | |
| MousePheno | abnormal cholesterol homeostasis | 3.16e-03 | 936 | 38 | 8 | MP:0005278 | |
| Domain | Cyt_P450_mitochondrial | 5.18e-06 | 2 | 43 | 2 | IPR002399 | |
| Domain | GPR40-rel_orph | 3.10e-05 | 4 | 43 | 2 | IPR013312 | |
| Domain | Calpain_cysteine_protease | 4.63e-04 | 14 | 43 | 2 | IPR022684 | |
| Domain | CysPc | 5.33e-04 | 15 | 43 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 5.33e-04 | 15 | 43 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 5.33e-04 | 15 | 43 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 5.33e-04 | 15 | 43 | 2 | PS50203 | |
| Domain | RRM_dom_euk | 1.27e-03 | 23 | 43 | 2 | IPR003954 | |
| Domain | RRM_1 | 1.27e-03 | 23 | 43 | 2 | SM00361 | |
| Domain | THIOL_PROTEASE_CYS | 1.62e-03 | 26 | 43 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 1.75e-03 | 27 | 43 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 1.75e-03 | 27 | 43 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 1.88e-03 | 28 | 43 | 2 | IPR000169 | |
| Domain | Cyt_P450_CS | 6.62e-03 | 53 | 43 | 2 | IPR017972 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 9.68e-06 | 20 | 30 | 3 | MM1496 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.94e-05 | 25 | 30 | 3 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 2.46e-05 | 27 | 30 | 3 | MM14844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 4.36e-05 | 5 | 30 | 2 | M47522 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 4.98e-05 | 34 | 30 | 3 | M27461 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 5.92e-05 | 36 | 30 | 3 | M27081 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 8.78e-05 | 41 | 30 | 3 | MM14757 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.39e-04 | 126 | 30 | 4 | MM15553 | |
| Pathway | REACTOME_RECYCLING_OF_EIF2_GDP | 1.56e-04 | 9 | 30 | 2 | MM15418 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 1.95e-04 | 10 | 30 | 2 | MM1469 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS | 1.95e-04 | 10 | 30 | 2 | MM17234 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.95e-04 | 10 | 30 | 2 | M27076 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 1.95e-04 | 10 | 30 | 2 | MM1394 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 2.38e-04 | 11 | 30 | 2 | MM14750 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 2.85e-04 | 12 | 30 | 2 | MM15927 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 2.85e-04 | 12 | 30 | 2 | MM14981 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 2.85e-04 | 12 | 30 | 2 | MM14749 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.01e-04 | 154 | 30 | 4 | M27832 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.32e-04 | 64 | 30 | 3 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.64e-04 | 66 | 30 | 3 | MM14839 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 3.92e-04 | 14 | 30 | 2 | M46449 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 3.92e-04 | 14 | 30 | 2 | M46453 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 5.16e-04 | 16 | 30 | 2 | M39815 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 6.56e-04 | 18 | 30 | 2 | M39679 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 7.32e-04 | 19 | 30 | 2 | M16991 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.37e-03 | 104 | 30 | 3 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.41e-03 | 105 | 30 | 3 | MM14842 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 1.49e-03 | 27 | 30 | 2 | M27632 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 1.65e-03 | 111 | 30 | 3 | M48065 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.84e-03 | 250 | 30 | 4 | M27554 | |
| Pathway | WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS | 2.09e-03 | 32 | 30 | 2 | M39893 | |
| Pathway | WP_GPCRS_NONODORANT | 2.31e-03 | 266 | 30 | 4 | MM15843 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 25637492 | ||
| Pubmed | iCLIP predicts the dual splicing effects of TIA-RNA interactions. | 1.64e-06 | 2 | 45 | 2 | 21048981 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17651452 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23150505 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 34743356 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 1.64e-06 | 2 | 45 | 2 | 21164264 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 30478340 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 38040866 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20675271 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 1.64e-06 | 2 | 45 | 2 | 20339375 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 35408893 | ||
| Pubmed | FFAR3 modulates insulin secretion and global gene expression in mouse islets. | 1.64e-06 | 2 | 45 | 2 | 26091414 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 11514562 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20808686 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 27550964 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 8645611 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17488725 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 1.64e-06 | 2 | 45 | 2 | 35858247 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22506074 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 32073900 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 1.64e-06 | 2 | 45 | 2 | 12231255 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20634641 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 1303253 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 1.64e-06 | 2 | 45 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 1.64e-06 | 2 | 45 | 2 | 21625068 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 16110193 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26066897 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24748202 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24696465 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 36362376 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24086455 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 1741400 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 32540969 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26047574 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26324851 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18651133 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 7669222 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22083159 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24927121 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22933298 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 19339348 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20399779 | ||
| Pubmed | Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. | 1.64e-06 | 2 | 45 | 2 | 19630535 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 2783417 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 8871565 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 1.64e-06 | 2 | 45 | 2 | 2256920 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 16278295 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 1.64e-06 | 2 | 45 | 2 | 15699546 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18162527 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 38341019 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 1.64e-06 | 2 | 45 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 1.64e-06 | 2 | 45 | 2 | 16396990 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 24837548 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 30046010 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23110765 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 1.64e-06 | 2 | 45 | 2 | 19820005 | |
| Pubmed | Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. | 1.64e-06 | 2 | 45 | 2 | 8576255 | |
| Pubmed | The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. | 1.64e-06 | 2 | 45 | 2 | 26522986 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 20980400 | ||
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 1.64e-06 | 2 | 45 | 2 | 18397978 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 1518866 | ||
| Pubmed | Regulation of SREBP1c expression by mTOR signaling in hepatocytes. | 1.64e-06 | 2 | 45 | 2 | 20847591 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 14722361 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 27664183 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22622494 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18456862 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 1.64e-06 | 2 | 45 | 2 | 15062555 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 31541353 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23761669 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17075030 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17075029 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 1.64e-06 | 2 | 45 | 2 | 2592361 | |
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 1.64e-06 | 2 | 45 | 2 | 15507509 | |
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 1.64e-06 | 2 | 45 | 2 | 17296872 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 23314847 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 1.64e-06 | 2 | 45 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 1.64e-06 | 2 | 45 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 1.64e-06 | 2 | 45 | 2 | 15731365 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 1.64e-06 | 2 | 45 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 1.64e-06 | 2 | 45 | 2 | 19029289 | |
| Pubmed | Structure of the central RNA recognition motif of human TIA-1 at 1.95A resolution. | 1.64e-06 | 2 | 45 | 2 | 18201561 | |
| Pubmed | TIA-1 and TIAR interact with 5'-UTR of enterovirus 71 genome and facilitate viral replication. | 1.64e-06 | 2 | 45 | 2 | 26363455 | |
| Pubmed | TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. | 1.64e-06 | 2 | 45 | 2 | 10921895 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26260360 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 37019194 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 1.64e-06 | 2 | 45 | 2 | 16325480 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 15522937 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 22673524 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 36861295 | ||
| Pubmed | SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer. | 4.91e-06 | 3 | 45 | 2 | 29784665 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 36778748 | ||
| Pubmed | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 4.91e-06 | 3 | 45 | 2 | 8111631 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 2546938 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16118390 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12496283 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 34204880 | ||
| Pubmed | Interaction of CYP11B1 (cytochrome P-45011 beta) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. | 4.91e-06 | 3 | 45 | 2 | 10411633 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 2.35e-04 | 307 | 45 | 4 | chr17q25 | |
| Cytoband | 19q13.1 | 1.35e-03 | 55 | 45 | 2 | 19q13.1 | |
| GeneFamily | Cytochrome P450 family 11 | 6.93e-06 | 3 | 28 | 2 | 1007 | |
| GeneFamily | C2 domain containing|Calpains | 2.40e-04 | 15 | 28 | 2 | 975 | |
| GeneFamily | Fibronectin type III domain containing | 2.53e-02 | 160 | 28 | 2 | 555 | |
| Drug | cyadox | 3.48e-06 | 2 | 43 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 3.48e-06 | 2 | 43 | 2 | ctd:C042509 | |
| Drug | Depsipeptides | 8.15e-06 | 21 | 43 | 3 | ctd:D047630 | |
| Drug | 18-hydroxycortisol | 1.04e-05 | 3 | 43 | 2 | ctd:C033689 | |
| Drug | C05489 | 2.09e-05 | 4 | 43 | 2 | CID000440708 | |
| Drug | 17alpha, 21-dihydroxypregnenolone | 3.47e-05 | 5 | 43 | 2 | CID000192735 | |
| Drug | Xylose | 3.47e-05 | 5 | 43 | 2 | ctd:D014994 | |
| Drug | Methandrostenolone | 5.20e-05 | 6 | 43 | 2 | ctd:D008696 | |
| Drug | Tetrahydronaphthalenes | 5.20e-05 | 6 | 43 | 2 | ctd:D013764 | |
| Drug | triheptanoin | 7.27e-05 | 7 | 43 | 2 | CID000069286 | |
| Drug | Cortodoxone | 7.27e-05 | 7 | 43 | 2 | ctd:D003350 | |
| Drug | Androstenedione | 8.42e-05 | 45 | 43 | 3 | ctd:D000735 | |
| Drug | 2,2',3,3',4,6'-hexachlorobiphenyl | 9.69e-05 | 8 | 43 | 2 | ctd:C094859 | |
| Drug | 2,2',3,4',5',6-hexachlorobiphenyl | 1.24e-04 | 9 | 43 | 2 | ctd:C120129 | |
| Drug | GKT137831 | 1.24e-04 | 9 | 43 | 2 | ctd:C576694 | |
| Drug | platycodin D | 1.24e-04 | 9 | 43 | 2 | ctd:C108953 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 2.27e-06 | 2 | 45 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 2.27e-06 | 2 | 45 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Glucocorticoid-remediable aldosteronism | 2.27e-06 | 2 | 45 | 2 | C1260386 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 6.24e-06 | 171 | 45 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 6.82e-06 | 3 | 45 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 2.27e-05 | 5 | 45 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Hyperaldosteronism | 3.40e-05 | 6 | 45 | 2 | C0020428 | |
| Disease | hypopituitarism (implicated_via_orthology) | 3.40e-05 | 6 | 45 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Conn Syndrome | 3.40e-05 | 6 | 45 | 2 | C1384514 | |
| Disease | hypertension (implicated_via_orthology) | 4.39e-05 | 128 | 45 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | protocadherin alpha-7 measurement | 4.75e-05 | 7 | 45 | 2 | EFO_0801973 | |
| Disease | Intellectual Disability | 5.77e-05 | 447 | 45 | 6 | C3714756 | |
| Disease | leukodystrophy (implicated_via_orthology) | 8.13e-05 | 9 | 45 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | protein FAM163B measurement | 8.13e-05 | 9 | 45 | 2 | EFO_0802936 | |
| Disease | androstenedione measurement | 1.02e-04 | 10 | 45 | 2 | EFO_0007972 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.24e-04 | 11 | 45 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.24e-04 | 11 | 45 | 2 | EFO_0021862 | |
| Disease | aspartate aminotransferase measurement | 4.07e-04 | 904 | 45 | 7 | EFO_0004736 | |
| Disease | apolipoprotein L1 measurement | 6.67e-04 | 25 | 45 | 2 | EFO_0021854 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 8.38e-04 | 28 | 45 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | bowel opening frequency | 9.63e-04 | 30 | 45 | 2 | EFO_0600084 | |
| Disease | brain infarction (biomarker_via_orthology) | 1.17e-03 | 33 | 45 | 2 | DOID:3454 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.47e-03 | 147 | 45 | 3 | DOID:9352 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLWRQRLLQSRLVEW | 941 | Q5SNV9 | |
| IQWNQRWGRRPSNRS | 411 | P30988 | |
| AIGGQWWRRRAQLTR | 351 | P18089 | |
| ILLLRIQNPWGRRCW | 256 | Q9HC96 | |
| GWWVRNINTLRRCIE | 1636 | Q8TDJ6 | |
| VRWRQQWLENGTLLF | 106 | O14525 | |
| LLVQELWRARPGWAR | 236 | Q5U651 | |
| ERGLWRSLGQWTIQQ | 616 | Q8IXQ6 | |
| RLLRLRNPWGRFSWN | 731 | O75808 | |
| QRLWQRPWLRTAGLG | 36 | Q6PK18 | |
| VRQARGQRLEWIGWI | 56 | A0A0C4DH39 | |
| QQLENIWWQRDGRLL | 231 | Q6P1M3 | |
| WQIQRWWQLGRLRQL | 51 | Q5VYM1 | |
| RVLLQAARGTWWNRP | 16 | Q6P4F2 | |
| WRGARLVQSVLRVWQ | 6 | O75616 | |
| ARWQQVWLLALERQR | 3121 | O94854 | |
| NRAAPWGTRRLLNWI | 1246 | P09848 | |
| NWLQTGWISRGRGQR | 86 | Q5JZY3 | |
| LRRLCGLWGQWQQES | 291 | O15529 | |
| LQRRQRLQLGRWQGW | 396 | Q96JP2 | |
| LLWQIFGNQGNRWIR | 971 | Q5VYJ5 | |
| QLWQRLWEVQDGRRL | 171 | Q5EBM0 | |
| LRRLCGLWGQWQQES | 291 | O14843 | |
| GNRWLRLLQIWREQG | 46 | P15538 | |
| SRARRVLQWWQGCRG | 461 | Q96PX6 | |
| RLQWTWLGRAELQFG | 1751 | Q8IWT3 | |
| LEAERRGQQRWIQNW | 76 | Q96LR7 | |
| GNRWLRLLQIWREQG | 46 | P19099 | |
| WRLIGWGQIRRGVTI | 451 | Q2VIR3 | |
| SWNQRARWLRGILLF | 2606 | Q8TDX9 | |
| RREIIRQIWWERLQG | 1611 | P42345 | |
| RQIWWERLQGCQRIV | 1616 | P42345 | |
| QLRDWGVRRWPNQLI | 76 | A6NC51 | |
| RGRLALQWRQVSWIT | 11 | Q8N967 | |
| LQRLWVGRWLAGRAG | 636 | P36956 | |
| QGEENLLAILRRRWW | 116 | Q5T1Q4 | |
| IGWLVRWKRRNNVGF | 121 | Q6B0B8 | |
| EGLWKWNDRILRLQN | 166 | Q9P2J8 | |
| AGVQTLRWQRWQRRR | 56 | Q8IU68 | |
| QLEGWRWNRPGDRIL | 136 | Q12800 | |
| GQTWARRALLLGILW | 6 | Q71RS6 | |
| LLLQEGSQRRLWRWC | 11 | Q96A28 | |
| TGRLLVGLRWWNQID | 81 | A6NH52 | |
| QGILRQNEQRWRWIF | 886 | Q7Z2W7 | |
| QWLGGRQIRTNWATR | 161 | Q01085 | |
| NWRQPLQRLLWGLEG | 96 | Q8WW34 | |
| WLGGRQIRTNWATRK | 171 | P31483 | |
| WRLIGWGQIRRGVTI | 451 | P41091 |